Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing
Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing
On CNBC's "Mad Money Lightning Round," Jim Cramer believes in Moderna, Inc. (NASDAQ:MRNA).
在CNBC的 “疯狂金钱闪电回合” 中，吉姆·克莱默相信摩德纳公司（纳斯达克股票代码：MRNA）。
On May 14, Evercore ISI Group analyst Cory Kasimov initiated coverage on Moderna with an In-Line rating and announced a price target of $120.
5月14日，Evercore ISI集团分析师科里·卡西莫夫以在线评级启动了对Moderna的报道，并宣布目标股价为120美元。
The "Mad Money" host likes Mind Medicine (MindMed) Inc. (NASDAQ:MNMD). "Anything that makes it so that there's ways to be able to get rid of pain and do good without getting people hooked, I am all in on. Doesn't necessarily mean it will make a lot of money, I don't care," he added.
这位 “疯狂的钱” 主持人喜欢心灵医学（MindMed）公司（纳斯达克股票代码：MNMD）。“任何能够在不被人迷住的情况下摆脱痛苦和做好事的办法，我都会全力以赴。这并不一定意味着它会赚很多钱，我不在乎，” 他补充说。
On May 13, Oppenheimer analyst Francois Brisebois reiterated Mind Medicine with an Outperform and lowered the price target from $29 to $20.
5月13日，奥本海默分析师弗朗索瓦·布里塞波依斯重申了Mind Medicine的跑赢大盘，并将目标股价从29美元下调至20美元。
"I don't want you to sell, and I don't want you to double down," Cramer said when asked about Hertz Global Holdings, Inc. (NASDAQ:HTZ). "Let's just see if it can't go higher."
当被问及赫兹环球控股公司（纳斯达克股票代码：HTZ）时，克莱默说：“我不想让你卖出，也不想让你加倍下跌。”“让我们看看它是否不能走得更高。”
On April 25, Hertz Global reported mixed first-quarter financial results.
4月25日，赫兹环球公布的第一季度财务业绩喜忧参半。
Cramer recommended buying Modine Manufacturing Company (NYSE:MOD). "That kind of metal-bending industrial company is precisely what's working here," he added.
克莱默建议收购摩丁制造公司（纽约证券交易所代码：MOD）。他补充说：“这种金属弯曲工业公司正是在这里工作的。”
Modine is scheduled to host a conference call and webcast to discuss its fourth quarter and fiscal year 2024 financial results on Wednesday, May 22.
Modine计划于5月22日星期三举行电话会议和网络直播，讨论其第四季度和2024财年的财务业绩。
AMETEK, Inc. (NYSE:AME) is a buy, Cramer said. It is an "absolutely terrific" company.
克莱默说，阿美特克公司（纽约证券交易所代码：AME）值得买入。这是一家 “绝对很棒” 的公司。
On May 2, AMETEK reported worse-than-expected first-quarter sales results.
5月2日，AMETEK公布的第一季度销售业绩低于预期。
When asked about Palantir Technologies Inc. (NYSE:PLTR), he said, "The quarters are uneven."
当被问及帕兰蒂尔科技公司（纽约证券交易所代码：PLTR）时，他说：“季度不均衡。”
On May 6, Palantir said first-quarter revenue increased 21% year-over-year to $634 million, which beat the consensus estimate of $625.431 million, according to Benzinga Pro.
5月6日，帕兰蒂尔表示，根据Benzinga Pro的数据，第一季度收入同比增长21％，达到6.34亿美元，超过了市场普遍预期的6.25431亿美元。
Price Action:
价格走势：
- Moderna shares rose 2.1% to settle at $128.32 on Tuesday.
- MindMed shares rose 0.5% to close at $8.49.
- Modine Manufacturing shares rose 4.4% to settle at $105.66 on Tuesday.
- AMETEK shares fell 0.9% to settle at $168.53.
- Hertz shares rose 9.7% to close at $6.00 on Tuesday.
- Palantir shares rose 2.4% to settle at $21.44 on Tuesday.
- 周二，摩德纳股价上涨2.1％，收于128.32美元。
- MindMed股价上涨0.5％，收于8.49美元。
- 周二，摩丁制造公司股价上涨4.4％，收于105.66美元。
- 阿美特克股价下跌0.9％，收于168.53美元。
- 赫兹股价周二上涨9.7％，收于6.00美元。
- 周二，帕兰蒂尔股价上涨2.4％，收于21.44美元。
Image: Shutterstock
图片：Shutterstock